Research ArticleArticle
Three-dimensional Volumetric Ultrasound: A Valid Method for Blinded Assessment of Response to Therapy in Rheumatoid Arthritis
Esperanza Naredo, Carlos Acebes, Elia Brito, Juan José de Agustín, Eugenio de Miguel, Lucía Mayordomo, Ingrid Möller, Carmen Moragues, Eduardo Rejón, Ana Rodriguez, Jacqueline Uson, Jesús Garrido, David Martínez-Hernández, The Ultrasound School of the Spanish Society of Rheumatology and David Martínez-Hernández, The Ultrasound School of the Spanish Society of Rheumatology
The Journal of Rheumatology January 2013, jrheum.121103; DOI: https://doi.org/10.3899/jrheum.121103
Esperanza Naredo
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Carlos Acebes
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Elia Brito
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Juan José de Agustín
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Eugenio de Miguel
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Lucía Mayordomo
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Ingrid Möller
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Carmen Moragues
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Eduardo Rejón
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Ana Rodriguez
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Jacqueline Uson
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Jesús Garrido
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
David Martínez-Hernández
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
David Martínez-Hernández
From the Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; Department of Rheumatology, Fundación Jiménez Díaz; Department of Rheumatology, Hospital Ramón y Cajal; Department of Rheumatology, Hospital Universitario La Paz; Department of Rheumatology, Hospital Universitario de Móstoles; Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University, Madrid; Department of Rheumatology, Hospital Vall d’Hebrón; Department of Rheumatology, Instituto Poal; Department of Rheumatology, Hospital de Bellvitge, Barcelona; and Hospital Universitario de Valme, Seville, Spain. Supported by Roche Farma S.A. E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón and Complutense University; C. Acebes, MD, PhD, Department of Rheumatology, Fundación Jiménez Díaz; E. Brito, MD, Department of Rheumatology, Hospital Ramón y Cajal; J.J. de Agustín, MD, PhD, Department of Rheumatology, Hospital Vall d’Hebrón; E. de Miguel, MD, PhD, Department of Rheumatology, Hospital Universitario La Paz; L. Mayordomo, MD, Department of Rheumatology, Hospital Universitario de Valme; I. Möller, MD, PhD, Department of Rheumatology, Instituto Poal; C. Moragues, MD, Department of Rheumatology, Hospital de Bellvitge; E. Rejón, MD, Department of Rheumatology, Hospital Universitario de Valme; A. Rodriguez, MD, Department of Rheumatology, Hospital Ramón y Cajal; J. Uson, MD, Department of Rheumatology, Hospital Universitario de Móstoles; J. Garrido, MD, PhD, Department of Social Psychology and Methodology, Faculty of Psychology, Autonoma University; D. Martínez-Hernández, MD, PhD, Department of Preventive Medicine and Public Health, Faculty of Medicine, Complutense University. Address correspondence to Dr. E. Naredo, Rheumatology Department, Hospital General Universitario Gregorio Marañón, Doctor Alvarez Sierra 4, 4A, 28033 Madrid, Spain. E-mail: enaredo@ser.es. Accepted for publication November 8, 2012.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Three-dimensional Volumetric Ultrasound: A Valid Method for Blinded Assessment of Response to Therapy in Rheumatoid Arthritis
Esperanza Naredo, Carlos Acebes, Elia Brito, Juan José de Agustín, Eugenio de Miguel, Lucía Mayordomo, Ingrid Möller, Carmen Moragues, Eduardo Rejón, Ana Rodriguez, Jacqueline Uson, Jesús Garrido, David Martínez-Hernández, The Ultrasound School of the Spanish Society of Rheumatology, David Martínez-Hernández, The Ultrasound School of the Spanish Society of Rheumatology
The Journal of Rheumatology Jan 2013, jrheum.121103; DOI: 10.3899/jrheum.121103
Three-dimensional Volumetric Ultrasound: A Valid Method for Blinded Assessment of Response to Therapy in Rheumatoid Arthritis
Esperanza Naredo, Carlos Acebes, Elia Brito, Juan José de Agustín, Eugenio de Miguel, Lucía Mayordomo, Ingrid Möller, Carmen Moragues, Eduardo Rejón, Ana Rodriguez, Jacqueline Uson, Jesús Garrido, David Martínez-Hernández, The Ultrasound School of the Spanish Society of Rheumatology, David Martínez-Hernández, The Ultrasound School of the Spanish Society of Rheumatology
The Journal of Rheumatology Jan 2013, jrheum.121103; DOI: 10.3899/jrheum.121103